ArticleVaccines2021
Evaluating the Geographical Accessibility and Equity of COVID-19 Vaccination Sites in England.
Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Household and Community Clustering of Concurrent Vaccine Hesitancy in China: Multicenter Survey.JMIR public health and surveillance · 2026Article
- COVID-19 Vaccination Site Accessibility, United States, December 11, 2020-March 29, 2022.Emerging infectious diseases · 2024Article
- Understanding the spatial heterogeneity of COVID-19 vaccination uptake in England.BMC public health · 2023Article
- Mind the gap: Data availability, accessibility, transparency, and credibility during the COVID-19 pandemic, an international comparative appraisal.PLOS global public health · 2023Article
- Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India.Frontiers in public health · 2023Article
- Assessing the spatial variability of raising public risk awareness for the intervention performance of COVID-19 voluntary screening: A spatial simulation approach.Applied geography (Sevenoaks, England) · 2022Article
- Article
- Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.European journal of epidemiology · 2022Article
- Effects of Social Vulnerability and Spatial Accessibility on COVID-19 Vaccination Coverage: A Census-Tract Level Study in Milwaukee County, USA.International journal of environmental research and public health · 2022Article
- Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.medRxiv : the preprint server for health sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We assess the geographical accessibility of COVID-19 vaccination sites-including mass vaccination centers and community-level provision-in England utilizing open data from NHS England and detailed routing data from HERE Technologies. We aim to uncover inequity in vaccination site accessibility, highlighting small-area inequality hidden by coverage figures released by the NHS. Vaccination site accessibility measures are constructed at a neighborhood level using indicators of journey time by private and public transport. We identify inequity in vaccination-site accessibility at the neighborhood level, driven by region of residence, mode of transport (specifically availability of private transport), rural-urban geography and the availability of GP-led services. We find little evidence that accessibility to COVID-19 vaccination sites is related to underlying area-based deprivation. We highlight the importance of GP-led provision in maintaining access to vaccination services at a local level and reflect on this in the context of phase 3 of the COVID-19 vaccination programme (booster jabs) and other mass vaccination programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.